The DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
Environmental Obesogens: Organotins and Endocrine Disruption via Nuclear Receptor Signaling
Abstract
Over the last two decades, the incidence of obesity and associated metabolic syndrome diseases has risen dramatically, becoming a global health crisis. Increased caloric intake and decreased physical activity are believed to represent the root causes of this dramatic rise. However, recent findings highlight the possible involvement of environmental obesogens, xenobiotic chemicals that can disrupt the normal developmental and homeostatic controls over adipogenesis and energy balance. Environmental estrogens, i.e. chemicals with estrogenic potential, have been reported to perturb adipogenic mechanisms using in vitro model systems, but other classes of endocrine-disrupting chemicals are now coming under scrutiny as well. Organotins represent one class of widespread persistent organic pollutants with potent endocrine-disrupting properties in both invertebrates and vertebrates. New data identify tributyltin chloride and triphenyltin chloride as nanomolar agonist ligands for retinoid X receptor (RXR alpha, RXR beta, and RXR gamma) and peroxisome proliferator-activated receptor gamma, nuclear receptors that play pivotal roles in lipid homeostasis and adipogenesis. The environmental obesogen hypothesis predicts that inappropriate receptor activation by organotins will lead directly to adipocyte differentiation and a predisposition to obesity and/or will sensitize exposed individuals to obesity and related metabolic disorders under the influence of the typical high-calorie, high-fat Western diet. The linking of organotin exposure to adipocyte differentiation and obesity opens an important new area of research into potential environmental influences on human health and disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001
Mokdad, A. H., Ford, E. S., Bowman, B. A., Dietz, W. H., Vinicor, F., Bales, V. S., & Marks, J. S. (2003) · JAMA · doi:10.1001/jama.289.1.76 · Cited by 5,866
Environmental Contributions to the Obesity Epidemic
Hill, J. O., & Peters, J. C. (1998) · Science · doi:10.1126/science.280.5368.1371 · Cited by 2,222
Diabetes mellitus: a "thrifty" genotype rendered detrimental by "progress"?
(1962) · PubMed Central · Cited by 2,182
Fetal and placental size and risk of hypertension in adult life.
Barker, D. J., Bull, A. R., Osmond, C., & Simmonds, S. J. (1990) · BMJ · doi:10.1136/bmj.301.6746.259 · Cited by 1,728
PPARs and the complex journey to obesity
Evans, R. M., Barish, G. D., & Wang, Y.-X. (2004) · Nature Medicine · doi:10.1038/nm1025 · Cited by 1,602
Increased adipose tissue in male and female estrogen receptor-α knockout mice
Heine, P. A., Taylor, J. A., Iwamoto, G. A., Lubahn, D. B., & Cooke, P. S. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.23.12729 · Cited by 1,282
The Biology of Peroxisome Proliferator-Activated Receptors
Ferré, P. (2004) · Diabetes · doi:10.2337/diabetes.53.2007.s43 · Cited by 776
Growth in utero and serum cholesterol concentrations in adult life.
Barker, D. J., Martyn, C. N., Osmond, C., Hales, C. N., & Fall, C. H. (1993) · BMJ · doi:10.1136/bmj.307.6918.1524 · Cited by 628
Programming by Early Nutrition: An Experimental Approach
Lucas, A. (1998) · The Journal of Nutrition · doi:10.1093/jn/128.2.401s · Cited by 621
Critical appraisal of the evidence for tributyltin-mediated endocrine disruption in mollusks
Matthiessen, P., & Gibbs, P. E. (1998) · Environmental Toxicology and Chemistry · doi:10.1002/etc.5620170106 · Cited by 613
PPARγ, the ultimate thrifty gene
Auwerx, J. (1999) · Diabetologia · doi:10.1007/s001250051268 · Cited by 612
Endocrine-Disrupting Organotin Compounds Are Potent Inducers of Adipogenesis in Vertebrates
Grün, F., Watanabe, H., Zamanian, Z., Maeda, L., Arima, K., Cubacha, R., Gardiner, D. M., Kanno, J., Iguchi, T., & Blumberg, B. (2006) · Molecular Endocrinology · doi:10.1210/me.2005-0367 · Cited by 612
Self-citationSensitization of diabetic and obese mice to insulin by retinoid X receptor agonists
Mukherjee, R., Davies, P. J. A., Crombie, D. L., Bischoff, E. D., Cesario, R. M., Jow, L., Hamann, L. G., Boehm, M. F., Mondon, C. E., Nadzan, A. M., et al. (1997) · Nature · doi:10.1038/386407a0 · Cited by 605
How Obesity Causes Diabetes: Not a Tall Tale
Lazar, M. A. (2005) · Science · doi:10.1126/science.1104342 · Cited by 568
Chemical Toxins: A Hypothesis to Explain the Global Obesity Epidemic
Baillie-Hamilton, P. F. (2002) · The Journal of Alternative and Complementary Medicine · doi:10.1089/107555302317371479 · Cited by 562
Armitage, J. A., Khan, I. Y., Taylor, P. D., Nathanielsz, P. W., & Poston, L. (2004) · The Journal of Physiology · doi:10.1113/jphysiol.2004.072009 · Cited by 530
Peroxisome proliferator-activated receptor γ in diabetes and metabolism
Rangwala, S. M., & Lazar, M. A. (2004) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2004.03.012 · Cited by 450
Thiazolidinediones: a new class of antidiabetic drugs
Day, C. (1999) · Diabetic Medicine · doi:10.1046/j.1464-5491.1999.00023.x · Cited by 436
Boyer, I. J. (1989) · Toxicology · doi:10.1016/0300-483x(89)90018-8 · Cited by 423
Growth in utero, adult blood pressure, and arterial compliance.
Martyn, C. N., Barker, D. J., Jespersen, S., Greenwald, S., Osmond, C., & Berry, C. (1995) · Heart · doi:10.1136/hrt.73.2.116 · Cited by 362
Kanayama, T., Kobayashi, N., Mamiya, S., Nakanishi, T., & Nishikawa, J.-I. (2005) · Molecular Pharmacology · doi:10.1124/mol.104.008409 · Cited by 354
Dang, Z.-C., Audinot, V., Papapoulos, S. E., Boutin, J. A., & Löwik, C. W. G. M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209483200 · Cited by 323
Nishikawa, J.-I., Mamiya, S., Kanayama, T., Nishikawa, T., Shiraishi, F., & Horiguchi, T. (2004) · Environmental Science & Technology · doi:10.1021/es049593u · Cited by 322
T RANSCRIPTIONAL C ONTROL OF A DIPOGENESIS
Rangwala, S. M., & Lazar, M. A. (2000) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.20.1.535 · Cited by 319
McAllister, B. G., & Kime, D. E. (2003) · Aquatic Toxicology · doi:10.1016/s0166-445x(03)00154-1 · Cited by 265
The Soy Isoflavone Genistein Decreases Adipose Deposition in Mice
Naaz, A., Yellayi, S., Zakroczymski, M. A., Bunick, D., Doerge, D. R., Lubahn, D. B., Helferich, W. G., & Cooke, P. S. (2003) · Endocrinology · doi:10.1210/en.2003-0076 · Cited by 264
Role of macrophage tissue infiltration in metabolic diseases
Bouloumié, A., Curat, C. A., Sengenès, C., Lolmède, K., Miranville, A., & Busse, R. (2005) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/01.mco.0000172571.41149.52 · Cited by 262
Differential effects of flavonoids on 3T3-L1 adipogenesis and lipolysis
Harmon, A. W., & Harp, J. B. (2001) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.2001.280.4.c807 · Cited by 262
Occurrence of Butyltin Compounds in Human Blood
Kannan, K., Senthilkumar, K., & Giesy, J. P. (1999) · Environmental Science & Technology · doi:10.1021/es990011w · Cited by 261
Yajnik, C. (2000) · Proceedings of the Nutrition Society · doi:10.1017/s0029665100000288 · Cited by 256
Masuno, H., Kidani, T., Sekiya, K., Sakayama, K., Shiosaka, T., Yamamoto, H., & Honda, K. (2002) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)30108-5 · Cited by 233
Tomlinson, J. W., Moore, J., Cooper, M. S., Bujalska, I., Shahmanesh, M., Burt, C., Strain, A., Hewison, M., & Stewart, P. M. (2001) · Endocrinology · doi:10.1210/endo.142.5.8168 · Cited by 222
Danilovich, N., Babu, P. S., Xing, W., Gerdes, M., Krishnamurthy, H., & Sairam, M. R. (2000) · Endocrinology · doi:10.1210/endo.141.11.7765 · Cited by 203
Gao, Y., Holloway, A. C., Zeng, Z., Lim, G. E., Petrik, J. J., Foster, W. G., & Lee, R. M. K. W. (2005) · Obesity Research · doi:10.1038/oby.2005.77 · Cited by 197
Butyltin residues in livers of humans and wild terrestrial mammals and in plastic products
Takahashi, S., Mukai, H., Tanabe, S., Sakayama, K., Miyazaki, T., & Masuno, H. (1999) · Environmental Pollution · doi:10.1016/s0269-7491(99)00068-8 · Cited by 192
Childhood obesity is associated with maternal smoking in pregnancy
Toschke, A., Koletzko, B., Slikker, W., Hermann, M., & von Kries, R. (2002) · European Journal of Pediatrics · doi:10.1007/s00431-002-0983-z · Cited by 187
Endocrine Disruptors and the Obesity Epidemic
Heindel, J. J. (2003) · Toxicological Sciences · doi:10.1093/toxsci/kfg255 · Cited by 173
Inhibition of human cytochrome P450 aromatase activity by butyltins
Heidrich, D. (2001) · Steroids · doi:10.1016/s0039-128x(01)00108-8 · Cited by 164
Saitoh, M., Yanase, T., Morinaga, H., Tanabe, M., Mu, Y.-M., Nishi, Y., Nomura, M., Okabe, T., Goto, K., Takayanagi, R., et al. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5952 · Cited by 145
Yi-ming, M., Yanase, T., Nishi, Y., WASEDA, N., Oda, T., Tanaka, A., Takayanagi, R., & Nawata, H. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2701 · Cited by 139
Fetal growth and insulin secretion in adult life
Phillips, D. I. W., Hirst, S. D., CLARK, P. M. S., Hales, C. N., & Osmond, C. (1994) · Diabetologia · doi:10.1007/bf00403378 · Cited by 134
Mechanisms of Injury in the Central Nervous System
Philbert, M. A., Billingsley, M. L., & Reuhl, K. R. (2000) · Toxicologic Pathology · doi:10.1177/019262330002800107 · Cited by 134
Gennari, A., Viviani, B., Galli, C. L., Marinovich, M., Pieters, R. H. H., & Corsini, E. (2000) · Toxicology and Applied Pharmacology · doi:10.1006/taap.2000.9076 · Cited by 133
Effect of organotins on human aromatase activity in vitro
Cooke, G. M. (2002) · Toxicology Letters · doi:10.1016/s0378-4274(01)00451-9 · Cited by 129
Trialkyltin Compounds Bind Retinoid X Receptor to Alter Human Placental Endocrine Functions
Nakanishi, T., Nishikawa, J., Hiromori, Y., Yokoyama, H., Koyanagi, M., Takasuga, S., Ishizaki, J.-I., Watanabe, M., Isa, S.-I., Utoguchi, N., et al. (2005) · Molecular Endocrinology · doi:10.1210/me.2004-0397 · Cited by 127
Liver X Receptors Downregulate 11β-Hydroxysteroid Dehydrogenase Type 1 Expression and Activity
Stulnig, T. M., Oppermann, U. C. T., Steffensen, K. R., Schuster, G. U., & Gustafsson, J.-Α. (2002) · Diabetes · doi:10.2337/diabetes.51.8.2426 · Cited by 126
Environmental chemical tributyltin augments adipocyte differentiation
Inadera, H., & Shimomura, A. (2005) · Toxicology Letters · doi:10.1016/j.toxlet.2005.05.015 · Cited by 125
Butyltin Compounds in Human Liver
Nielsen, J. B., & Strand, J. (2002) · Environmental Research · doi:10.1006/enrs.2001.4321 · Cited by 124
Endocrine Modulators in the Food Chain and Environment
Nilsson, R. (2000) · Toxicologic Pathology · doi:10.1177/019262330002800311 · Cited by 116
Effect of estrogen deficiency in the male: the ArKO mouse model
Murata, Y., Robertson, K. M., Jones, M. E. E., & Simpson, E. R. (2002) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(02)00090-4 · Cited by 111
PPARα Agonists Reduce 11β-Hydroxysteroid Dehydrogenase Type 1 in the Liver
Hermanowski‐Vosatka, A., Gerhold, D. L., Mundt, S. S., Loving, V. A., Lu, M., Chen, Y., Elbrecht, A., Wu, M. S., Doebber, T. W., Kelly, L. J., et al. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3966 · Cited by 104
Zimmet, P., & Thomas, C. (2003) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2003.01170.x · Cited by 103
Lo, S., Alléra, A., Albers, P., Heimbrecht, J., Jantzen, E., Klingmüller, D., & Steckelbroeck, S. (2003) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(03)00074-8 · Cited by 95
Ohno, S., Nakajima, Y., & Nakajin, S. (2005) · Steroids · doi:10.1016/j.steroids.2005.03.005 · Cited by 91
TRIPHENYLTIN AS A POTENTIAL HUMAN ENDOCRINE DISRUPTOR
Golub, M. S., & Doherty, J. D. (2004) · Journal of Toxicology and Environmental Health Part B · doi:10.1080/10937400490452705 · Cited by 89
TWO-GENERATION REPRODUCTIVE TOXICITY STUDY OF TRIBUTYLTIN CHLORIDE IN FEMALE RATS
Ogata, R., Omura, M., Shimasaki, Y., Kubo, K., Oshima, Y., Aou, S., & Inoue, N. (2001) · Journal of Toxicology and Environmental Health · doi:10.1080/15287390151126469 · Cited by 84
Atanasov, A. G., Nashev, L. G., Tam, S., Baker, M. E., & Odermatt, A. (2005) · Environmental Health Perspectives · doi:10.1289/ehp.8209 · Cited by 82
Mu, Y.-M., Yanase, T., Nishi, Y., Takayanagi, R., Goto, K., & Nawata, H. (2001) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(00)00457-3 · Cited by 80
Zhang, Y., & Mangelsdorf, D. J. (2002) · Molecular Interventions · doi:10.1124/mi.2.2.78 · Cited by 79
Peroxisome proliferator‐activated receptor γ: the more the merrier?
Argmann, C., Cock, T., & Auwerx, J. H. (2005) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2005.01456.x · Cited by 68
Masuno, H. (2003) · Toxicological Sciences · doi:10.1093/toxsci/kfg203 · Cited by 64
Koch, S. S. C., Dardashti, L. J., Cesario, R. M., Croston, G. E., Boehm, M. F., Heyman, R. A., & Nadzan, A. M. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm980621r · Cited by 59
Hill, S. Y., Shen, S., Locke, J., Rickin, E., & Lowers, L. (2005) · Psychiatry Research · doi:10.1016/j.psychres.2005.04.003 · Cited by 34
(1962) · Europe PMC (PubMed Central)
Cited by
Endocrine-Disrupting Chemicals: An Endocrine Society Scientific Statement
Diamanti-Kandarakis, E., Bourguignon, J.-P., Giudice, L. C., Hauser, R., Prins, G. S., Soto, A. M., Zoeller, R. T., & Gore, A. C. (2009) · Endocrine Reviews · doi:10.1210/er.2009-0002 · Cited by 4,585
EDC-2: the endocrine society's second scientific statement on endocrine-disrupting chemicals
Gore, A. C., Chappell, V. A., Fenton, S. E., Flaws, J. A., Nadal, A., Prins, G. S., Toppari, J., & Zoeller, R. T. (2015) · Endocrine Reviews · doi:10.1210/er.2015-1010 · Cited by 2,407
“How do EDCs make us fat? The 2006 study by Grun and Blumberg (167) that coined the term “obesogens” defined them as “xenobiotic chemicals that can disrupt the normal developmental and homeostatic controls over adipogenesis and/or energy balance.”
BackgroundInfluentialBisphenol A: An endocrine disruptor with widespread exposure and multiple effects
Rubin, B. S. (2011) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2011.05.002 · Cited by 1,410
State-of-the-science of endocrine disrupting chemicals, 2012
Bergman, Å., Heindel, J., Jobling, S., Kidd, K., & Zoeller, R. T. (2012) · Toxicology Letters · doi:10.1016/j.toxlet.2012.03.020 · Cited by 1,388
Metabolism disrupting chemicals and metabolic disorders
Heindel, J. J., Blumberg, B., Cave, M., Machtinger, R., Mantovani, A., Mendez, M. A., Nadal, A., Palanza, P., Panzica, G., Sargis, R., et al. (2017) · Reproductive Toxicology · doi:10.1016/j.reprotox.2016.10.001 · Cited by 1,101
“period can permanently alter the functioning of mesenchymal stem cells and lead to disruption of adipocyte function [299].”
Self-citation
Metadata
- Authors
- Grün, F., & Blumberg, B.
- Venue
- Endocrinology
- Publisher
- The Endocrine Society
- Published
- 2006-06-01
- Volume
- 147
- Issue
- 6
- Pages
- s50-s55
- ISSN
- 0013-7227 (ISSN-L)
- 1945-7170
- OpenAlex
- W2136138120
- Cited by
- 810
- References
- 64
- FWCI
- 15.65
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.